Related Experiment Videos
Chronic inflammation in FMF: markers, risk factors, outcomes and therapy
1Department of Medicine F, Sheba Medical Center, Tel-Hashomer 52621, Israel.
Abstract:
Familial Mediterranean fever (FMF) is the most common of the hereditary periodic fever syndromes. Although the typical clinical course of FMF is characterized by bouts of painful inflammation, this presentation represents only the tip of the iceberg. In many patients inflammation can persist in attack-free periods, as shown by high levels of acute-phase proteins, cytokines and inflammation-induced proteins. This subclinical inflammation puts patients at risk of developing complications such as anemia, splenomegaly, decreased bone mineral density, heart disease and life-threatening amyloid A amyloidosis, among others. In this article, we review the published data on markers and other factors involved in the persistence of inflammation in patients with FMF during attack-free periods, examine the risk factors for the development of this subclinical inflammation, summarize the complications of chronic inflammation in FMF and propose a new strategy for treatment, based on these data.
Insights
Familial Mediterranean fever (FMF) involves persistent subclinical inflammation even between attacks. This chronic inflammation increases the risk of serious complications, necessitating new treatment strategies.
Area of Science:
- Rheumatology
- Genetics
- Immunology
Background:
- Familial Mediterranean fever (FMF) is a common hereditary periodic fever syndrome.
- Clinical FMF attacks are only a part of the disease; subclinical inflammation persists between attacks.
- This persistent inflammation is indicated by elevated acute-phase proteins, cytokines, and inflammation-induced proteins.
Purpose of the Study:
- To review data on inflammation markers and factors during FMF attack-free periods.
- To examine risk factors for subclinical inflammation in FMF.
- To summarize chronic inflammation complications and propose new treatment strategies.
Main Methods:
- Literature review of published data on FMF inflammation.
- Analysis of markers and factors contributing to persistent inflammation.
- Synthesis of information on risk factors and complications.
Main Results:
- Subclinical inflammation is common in FMF patients between attacks.
- Persistent inflammation is linked to elevated inflammatory markers.
- Complications include anemia, splenomegaly, bone density loss, heart disease, and amyloidosis.
Conclusions:
- Subclinical inflammation in FMF is a significant concern, leading to severe complications.
- Understanding risk factors and markers is crucial for managing chronic inflammation.
- A novel treatment strategy targeting persistent inflammation is proposed.
Related Concept Videos
Chronic Inflammation: Introduction
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis I: Introduction
Inflammatory Bowel Disease III: Crohn's Disease
Inflammation
Inflammatory Bowel Disease II: Ulcerative Colitis